Jim Lordan

1.7k total citations
25 papers, 607 citations indexed

About

Jim Lordan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Genetics. According to data from OpenAlex, Jim Lordan has authored 25 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 3 papers in Genetics. Recurrent topics in Jim Lordan's work include Pulmonary Hypertension Research and Treatments (11 papers), Transplantation: Methods and Outcomes (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Jim Lordan is often cited by papers focused on Pulmonary Hypertension Research and Treatments (11 papers), Transplantation: Methods and Outcomes (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Jim Lordan collaborates with scholars based in United Kingdom, Ireland and Canada. Jim Lordan's co-authors include Paul A. Corris, Andrew J. Fisher, John H. Dark, Phil Botha, Kate Gould, Rachel Anderson, Chris Ward, Robert Rutherford, Melissa J. McDonnell and Anthony De Soyza and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Thorax.

In The Last Decade

Jim Lordan

25 papers receiving 594 citations

Peers

Countries citing papers authored by Jim Lordan

Since Specialization

Citations

This map shows the geographic impact of Jim Lordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Lordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Lordan more than expected).

Fields of papers citing papers by Jim Lordan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Lordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Lordan. The network helps show where Jim Lordan may publish in the future.

Co-authorship network of co-authors of Jim Lordan

This figure shows the co-authorship network connecting the top 25 collaborators of Jim Lordan. A scholar is included among the top collaborators of Jim Lordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Lordan. Jim Lordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single‐arm efficacy 2021 ·Pulmonary Circulation ·Martin R. Wilkins, Mikel A. McKie, Martin Law, Andreas–Antonios Roussakis, Lars Harbaum, Colin Church, (unknown), Robin Condliffe, Luke Howard, David G. Kiely, Jim Lordan, Alexander Rothman, Jay Suntharalingam, Mark Toshner, Stephen J. Wort, Sofía S. Villar	18
2	Perioperative Management of Pulmonary Hypertension. A Review 2021 ·SHILAP Revista de lepidopterología ·C. Wood, Mindaugas Balčiūnas, Jim Lordan, Adrian Mellor	6
3	A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk 2018 ·Respiratory Medicine ·Melissa J. McDonnell, Daniel O’Toole, Chris Ward, Jeffrey P. Pearson, Jim Lordan, Anthony De Soyza, Michael R. Loebinger, James D. Chalmers, John G. Laffey, Robert Rutherford	23
4	Successful outcome following pneumonectomy in a teenage boy with cystic fibrosis: a case report 2017 ·BMC Pulmonary Medicine ·(unknown), (unknown), Asif Hasan, F.K. Gould, Su Bunn, Matthew F. Thomas, Jim Lordan, Christopher J. O’Brien, Malcolm Brodlie	2
5	Observational Study of Methotrexate in the Treatment of Bronchiolitis Obliterans Syndrome 2016 ·Transplantation Proceedings ·(unknown), (unknown), (unknown), Andrew J. Fisher, Jim Lordan, (unknown), G. Parry, Paul A. Corris	8
6	A combination of two novel alpha globin variants Hb Bridlington (HBA1) and Hb Taybe (HBA2) resulting in severe hemolysis, pulmonary hypertension, and death 2014 ·Hematology ·Quentin A. Hill, (unknown), Jim Lordan, (unknown), Shirley Henderson	4
7	P160 The Role Of Specialist Palliative Care Services In The Management Of Patients With Pulmonary Arterial Hypertension; A Review Of Current Practice 2014 ·Thorax ·(unknown), (unknown), Rachel Crackett, (unknown), Andrew J. Fisher, Jim Lordan, Guy A. MacGowan, P.A. Corris	1
8	Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation 2014 ·Transplant International ·Monika Suwara, Bart Vanaudenaerde, Stijn E. Verleden, Robin Vos, (unknown), Chris Ward, Lee A. Borthwick, Elly Vandermeulen, Jim Lordan, Dirk Van Raemdonck, Paul A. Corris, Geert M. Verleden, Andrew J. Fisher	41
9	Functional and Quality of Life Improvements in Treated Patients with Chronic Thromboembolic Pulmonary Hypertension 2013 ·The Journal of Heart and Lung Transplantation ·M. Thakrar, Andrew G. Hall, Rachel Crackett, (unknown), (unknown), Jim Lordan, Andrew J. Fisher, (unknown), (unknown), Paul A. Corris	3
10	Phenotyping adults with non-cystic fibrosis bronchiectasis: A prospective observational cohort study 2013 ·Respiratory Medicine ·(unknown), Melissa J. McDonnell, S A Worthy, Stephen C Bourke, (unknown), Jim Lordan, Paul A. Corris, Anthony De Soyza, Peter G. Middleton, Chris Ward, Robert Rutherford	83
11	Treatment Outcomes in Pulmonary Arterial Hypertension (PHA) Associated with Systemic Sclerosis (Sscl.) in Matched Groups Using Either Bosentan or Sildenafil Monotherapy 2013 ·The Journal of Heart and Lung Transplantation ·Rachel Crackett, Albert D. Hall, (unknown), (unknown), Therese Small, Andrew J. Fisher, Jim Lordan, (unknown), P.A. Corris	1
12	Late-breaking abstract: Demographic trends and changes In long term outcome of incident idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension between 2001 to 2009. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland 2011 ·Yi Ling, Martin Johnson, David G. Kiely, Robin Condliffe, Charlie Elliot, Simon Gibbs, Luke Howard, Joanna Pepke‐Żaba, Karen Sheares, Paul A. Corris, (unknown), Jim Lordan, Seán Gaine, Gerry Coghlan, John Wort, Michael Α. Gatzoulis, Andrew J. Peacock	1
13	285* The impact of BMI on survival of patients with cystic fibrosis undergoing lung transplantation: a single centre experience 2011 ·Journal of Cystic Fibrosis ·Katy Hester, Sarah Wiscombe, G. Parry, Daniel C. Anthony, (unknown), Jim Lordan, AJ Fisher, Paul Corris	1
14	Inflammation and Epithelial to Mesenchymal Transition in Lung Transplant Recipients: Role in Dysregulated Epithelial Wound Repair 2010 ·American Journal of Transplantation ·Lee A. Borthwick, (unknown), (unknown), Malcolm Brodlie, Gail Johnson, Chris Ward, Jim Lordan, Paul A. Corris, John A. Kirby, Andrew J. Fisher	53
15	Pseudomonas aeruginosa Colonization of the Allograft After Lung Transplantation and the Risk of Bronchiolitis Obliterans Syndrome 2008 ·Transplantation ·Phil Botha, (unknown), Rachel Anderson, Jim Lordan, John H. Dark, Paul A. Corris, Kate Gould, Andrew J. Fisher	202
16	Morgagni Hernia Presenting With Bowel Obstruction in a Lung Transplant Recipient: Case Report 2008 ·Transplantation Proceedings ·C.H. Wigfield, (unknown), T. Butt, Bryon Jaques, Jim Lordan, S Barnard, Stephan Schueler	2
17	The Phosphodiesterase Type IV Inhibitor Cilomilast Decreases Pro-inflammatory Cytokine Production From Primary Bronchial Epithelial Cells in Lung Transplantation Patients 2006 ·The Journal of Heart and Lung Transplantation ·Denis J. Murphy, Chris Ward, (unknown), Gordon Pritchard, Dan Jones, Rachel Stovold, Amanda Fisher, Tim Cawston, Jim Lordan, Paul Corris	11
18	Evidence for Systemic Endothelial Dysfunction in Patients and First-Order Relatives With Pulmonary Arterial Hypertension 2005 ·CHEST Journal ·(unknown), (unknown), C.P. Oates, Jim Lordan, Paul A. Corris	23
19	Hypothesis: Epithelial-to-Mesenchymal Transition is a Common Cause of Chronic Allograft Failure 2005 ·Transplantation Proceedings ·Chris Ward, Helen Robertson, (unknown), Jim Lordan, Desmond M. Murphy, John H. Dark, P.A. Corris, David Jones, John A. Kirby	16
20	The pulmonary physician in critical care * Illustrative case 7: Assessment and management of massive haemoptysis 2003 ·Thorax ·Jim Lordan	100

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact